|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Immunology |
1 Department of Medicine, Hospital de Gastroenterología "Dr. Carlos Bonorino Udaondo", Buenos Aires, Argentina.
2 Pathology Service, Department of Medicine, Hospital de Gastroenterologiá, "Dr. Carlos Bonorino Udaondo", Buenos Aires, Argentina.
3 Unidad de Soporte Nutricional y Malabsorción, Hospital San Martín, La Plata, Argentina.
aAddress correspondence to this author at: Department of Medicine, Hospital de Gastroenterología "Carlos Bonorino Udaondo", Av. Caseros 2061, 1264 Buenos Aires, Argentina. Fax 54-11-4304-1018; e-mail jbai{at}intramed.net.
Background: Noninvasive serologic tests have shown high diagnostic accuracy for celiac disease (CD) in selected populations. Our aim was to determine prospectively the performance of CD-related serology in individuals undergoing intestinal biopsy because of clinical suspicion of small-bowel disorders.
Methods: We enrolled 141 unselected consecutive adult patients attending a small-bowel disease clinic. Patients underwent endoscopy and biopsy; serum samples were obtained at that time for measurements of anti–tissue transglutaminase (a-tTG), IgA and IgG anti–deamidated gliadin-related peptide (a-DGP), and IgA antiactin antibodies (AAAs). Characterization of patients was based on histological criteria (Marsh type II lesion or greater).
Results: The prevalence of CD was 42.5%. Sensitivity, specificity, and positive and negative predictive values were >90% for most assays. Diagnostic accuracy based on ROC curve analysis was similar for all assays [area under the curve (95% CI): 0.996 (0.967–0.998) for a-tTG, 0.995 (0.964–0.998) for IgA a-DGP, 0.989 (0.954–0.999) for IgG a-DGP, 0.996 (0.966–0.998) for blended conjugated of IgA + IgG a-DGP in a single assay, and 0.967 (0.922–0.990) for AAA]. The combinations of 2 tests, IgG a-DGP plus IgA a-tTG or the single blended conjugate detecting IgA + IgG a-DGP plus IgA a-tTG had 100% positive and negative predictive values if concentrations of both tests in either combination were above or below the cutoff.
Conclusions: In a population with high pretest probability, the newly developed a-DGP tests have diagnostic accuracy that is at least equivalent to that of established assays.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Parizade, Y. Bujanover, B. Weiss, V. Nachmias, and B. Shainberg Performance of Serology Assays for Diagnosing Celiac Disease in a Clinical Setting Clin. Vaccine Immunol., November 1, 2009; 16(11): 1576 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Basso, G. Guariso, P. Fogar, A. Meneghel, C.-F. Zambon, F. Navaglia, E. Greco, S. Schiavon, M. Rugge, and M. Plebani Antibodies against Synthetic Deamidated Gliadin Peptides for Celiac Disease Diagnosis and Follow-Up in Children Clin. Chem., January 1, 2009; 55(1): 150 - 157. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |